Results 221 to 230 of about 2,390,694 (316)

AI-generated text may have a role in evidence-based medicine. [PDF]

open access: yesNat Med, 2023
Peng Y   +3 more
europepmc   +1 more source

Reviews on evidence-based cancer medicine

open access: bronze, 1998
C. J. Williams, Jonathan J Deeks
openalex   +1 more source

FAM136A depletion induces mitochondrial stress and reduces mitochondrial membrane potential and ATP production

open access: yesFEBS Open Bio, EarlyView.
FAM136A depletion upregulated ROS production, reduced mitochondrial membrane potential (ΔΨ) and ATP production, and upregulated expression of PCK1, PCK2, HMGCS1, and HMGCS2. The expression of both TOMM22 and TOMM20 was also upregulated. FAM136A depletion reduced HCCS that produce holocytochrome c by combining heme to apocytochrome c, and reduced the ...
Yushi Otsuka, Masato Yano
wiley   +1 more source

The Recovery of Consciousness via Evidence-Based Medicine and Research (RECOVER) Program: A Paradigm for Advancing Neuroprognostication. [PDF]

open access: yesNeurol Clin Pract
Fischer D   +14 more
europepmc   +1 more source

Does the advertisement in Swiss pharmacy windows rest on evidence-based medicine? An observational study. [PDF]

open access: yesBMJ Open, 2023
Känzig T   +12 more
europepmc   +1 more source

Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon‐19‐deleted advanced NSCLC mutation

open access: yesFEBS Open Bio, EarlyView.
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy   +14 more
wiley   +1 more source

Evidence-based Medicine Using Oral and Nasal Observation; The Selection of Kampo Medicine in the Field of Otorhinoaryngology

open access: bronze, 1997
Toru Kaneko   +4 more
openalex   +2 more sources

Identification of inhibitors of the Salmonella FraB deglycase, a drug target

open access: yesFEBS Open Bio, EarlyView.
A high‐throughput screen was used to identify inhibitors of Salmonella FraB, a drug target. Characterization of top hits (identified after an additional counter screen) revealed that some triazolidines, thiadiazolidines, and triazolothiadiazoles are mixed‐type inhibitors of FraB.
Jamison D. Law   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy